Analyst Reco. Healthpeak Properties, Inc.

Equities

DOC

US42250P1030

Specialized REITs

Market Closed - Nyse Other stock markets 21:00:03 15/05/2026 BST			5-day change	1st Jan Change
19.36 ^USD	-1.02%		-1.53%	+20.40%

05-15	BNP Paribas Adjusts PT on Healthpeak Properties to $22 From $21, Maintains Outperform Rating	MT
05-14	RBC Raises Price Target on Healthpeak Properties to $21 From $20, Keeps Outperform Rating	MT

Analyst Reco.

05-15	BNP Paribas Adjusts PT on Healthpeak Properties to $22 From $21, Maintains Outperform Rating	MT
05-14	RBC Raises Price Target on Healthpeak Properties to $21 From $20, Keeps Outperform Rating	MT
05-13	UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept	MT
05-13	Jefferies Adjusts Price Target on Healthpeak Properties to $19 From $16, Maintains Hold Rating	MT
05-13	Baird Adjusts Price Target on Healthpeak Properties to $21 From $19, Maintains Outperform Rating	MT
05-12	Citigroup Adjusts PT on Healthpeak Properties to $20 From $17.50, Maintains Neutral Rating	MT
05-11	Evercore ISI Downgrades Healthpeak Properties to In Line From Outperform, Adjusts Price Target to $21 From $20	MT
05-07	Cantor Fitzgerald Adjusts Price Target on Healthpeak Properties to $20 From $17	MT
04-28	Morgan Stanley Adjusts Healthpeak Properties PT to $18 From $21, Maintains Overweight Rating	MT
04-20	UBS Initiates Healthpeak Properties at Neutral With $17 Price Target	MT
04-06	Evercore ISI Adjusts Healthpeak Properties Price Target to $20 From $19, Maintains Outperform Rating	MT
04-01	Citigroup Adjusts Price Target on Healthpeak Properties to $17.50 From $18, Maintains Neutral Rating	MT
02-06	Jefferies Adjusts Healthpeak Properties Price Target to $16 From $17, Maintains Hold Rating	MT
02-05	Argus Research Downgrades Healthpeak Properties to Hold From Buy	MT
02-03	Evercore ISI Adjusts Healthpeak Properties Price Target to $22 From $21	MT
02-03	BNP Paribas Adjusts Price Target on Healthpeak Properties to $21 From $22	MT
02-02	Wells Fargo Adjusts Healthpeak Properties PT to $18 From $19, Maintains Equal Weight Rating	MT
01-09	Mizuho Securities Adjusts Healthpeak Properties Price Target to $18 From $20, Maintains Outperform Rating	MT
01-09	Goldman Sachs Initiates Healthpeak Properties at Neutral With $17 Price Target	MT
12-16	Jefferies Downgrades Healthpeak Properties to Hold From Buy, Adjusts Price Target to $17 From $21	MT
12-15	Evercore ISI Adjusts PT on Healthpeak Properties to $21 From $22, Maintains Outperform Rating	MT
12-08	Raymond James Adjusts PT on Healthpeak Properties to $19 From $20, Maintains Outperform Rating	MT
11-24	Wells Fargo Adjusts Healthpeak Properties Price Target to $19 From $18, Maintains Equal Weight Rating	MT
11-14	JPMorgan Adjusts Price Target on Healthpeak Properties to $18 From $20, Maintains Neutral Rating	MT
11-12	Baird Adjusts Price Target on Healthpeak Properties to $20 From $21, Maintains Outperform Rating	MT